May 2020

More effective stem cell transplant

Scientists have developed a new way to make blood stem cells present in the umbilical cord “more transplantable”.

"AI research could pose risk for patients"

Many studies claiming that artificial intelligence (AI) is as good as, or better than, human experts at interpreting medical images are of poor quality and potentially exaggerated.

"Disasters lead to reductions in cancer screening"

Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan Earthquake of 2011.

COVID-19: a report from Malaysia and Singapore

Professor Anthony Rhodes and Dr Chooi Ling Lim discuss the COVID-19 spread and attempts to control the disease in Southeast Asia.

The Great Pestilence

The Black Death was the first great pandemic to devastate these shores and, unlike COVID-19, there was a special horror in the fact no-one knew what it was, states writer Jonathan Lovett.

COVID-19 statistics: an educated guess?

Adrian Esterman, Chair of Biostatistics at the University of South Australia’s Cancer Research Institute, asks: “Can we believe the statistics about COVID-19?”

Here to help: Virtual verification

IBMS Deputy Head of Education Jocelyn Pryce explains the new verification process and the impact that it had in just a few weeks.

Big question: “How do you think public approaches to health and wellbeing will change when the current pandemic is over?”

This month we ask “How do you think public approaches to health and wellbeing will change when the current pandemic is over?”

May tech news

Latest tech news for May.

Gene variant staves off Alzheimer's

People with a gene variant that puts them at high risk of Alzheimer’s disease are protected from its debilitating effects if they also carry a variant of a completely different gene, Stanford University School of Medicine investigators report in a new study.

Convalescent plasma therapy

A US team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centres rapidly scale up their ability to deliver so-called convalescent plasma therapy, which leverages immune system components found in the plasma portion of blood from people who have recovered from COVID-19.

Top